Formation of mixed-ligand Pd2+ complexes between canonical nucleoside 5'-monophosphates and five metal-ion-binding nucleoside analogs has been studied by 1H-NMR spectroscopy to test the ability of these nucleoside surrogates to discriminate between unmodified nucleobases by Pd2+-mediated base pairing. The nucleoside analogs studied included 2,6-bis(3,5-dimethylpyrazol-1-yl)-, 2,6-bis(1-methylhydrazinyl)- and 6-(3,5-dimethylpyrazol-1-yl)-substituted 9-(β-d-ribofuranosyl)purines 1–3, and 2,4-bis(3,5-dimethylpyrazol-1-yl)- and 2,4-bis(1-methylhydrazinyl)-substituted 5-(β-d-ribofuranosyl)-pyrimidines 4–5. Among these, the purine derivatives 1-3 bound Pd2+ much more tightly than the pyrimidine derivatives 4, 5 despite apparently similar structures of the potential coordination sites. Compounds 1 and 2 formed markedly stable mixed-ligand Pd2+ complexes with UMP and GMP, UMP binding favored by 1 and GMP by 2. With 3, formation of mixed-ligand complexes was retarded by binding of two molecules of 3 to Pd2+.
通过1H-NMR光谱研究了在标准核苷5'-单
磷酸和五种
金属离子结合核苷类似物之间形成混合
配体Pd2+复合物,以测试这些核苷替代物通过Pd2+介导的碱基配对区分未修饰核苷碱基的能力。研究的核苷类似物包括2,6-双(
3,5-二甲基吡唑-1-基)-、2,6-双(1-甲基
肼基)-和6-(
3,5-二甲基吡唑-1-基)-取代的9-(β-d-
呋喃核糖基)
嘌呤1-3,以及2,4-双(
3,5-二甲基吡唑-1-基)-和2,4-双(1-甲基
肼基)-取代的5-(β-d-
呋喃核糖基)
嘧啶4-5。其中,
嘌呤衍
生物1-3与Pd2+的结合比
嘧啶衍
生物4、5更紧密,尽管潜在配位位点的结构明显相似。化合物1和2与
UMP和GMP形成了明显稳定的混合
配体Pd2+复合物,
UMP与1结合,GMP与2结合。对于3,由于两个3